Agent for avoiding occlusion of shunts in substitute blood tubes

Details Agent for avoiding occlusion of shunts in substitute blood tubes Agent for avoiding occlusion of shunts in substitute blood tubes

1982-07-15

1986-04-01

Goldberg, Jerome D.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

A61K 3144

Patent

active

045798524

ABSTRACT:
The present invention relates to an agent for avoiding occlusion by thrombus of shunts and substitute blood tubes used in blood dialysis consisting of a compound selected from 5-(2-chlorobenzyl)-4,5,6, 7-tetrahydrothieno [3,2-c]pyridine and its therapeutically acceptable acid addition salts.
The therapeutically acceptable acid addition salt is, in particular, the hydrochloride, named Ticlopidine.

REFERENCES:
patent: 4051141 (1977-09-01), Castaigne

Affiliated with

Also associated with

Rating

Agent for avoiding occlusion of shunts in substitute blood tubes does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Agent for avoiding occlusion of shunts in substitute blood tubes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Agent for avoiding occlusion of shunts in substitute blood tubes will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1084640